
Bio-Rad Laboratories BIO
$ 307.08
-0.33%
Quarterly report 2025-Q2
added 07-31-2025
Bio-Rad Laboratories Total Shareholders Equity 2011-2025 | BIO
Annual Total Shareholders Equity Bio-Rad Laboratories
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.57 B | 8.74 B | 9.62 B | 13.7 B | 9.89 B | 5.76 B | 4.02 B | 2.93 B | 2.58 B | 2.49 B | 2.19 B | 2.19 B | 2.01 B | 1.74 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 13.7 B | 1.74 B | 5.31 B |
Quarterly Total Shareholders Equity Bio-Rad Laboratories
| 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7.13 B | 6.68 B | 7.49 B | 6.78 B | 9.05 B | 8.42 B | 8.45 B | 9.76 B | 9.62 B | 8.48 B | 8.95 B | 10.2 B | 13.7 B | 15.3 B | 11.6 B | 10.6 B | 9.88 B | 9.88 B | 9.88 B | 9.88 B | 5.76 B | 5.76 B | 5.76 B | 5.76 B | 4.02 B | 4.02 B | 4.02 B | 4.02 B | 2.93 B | 2.93 B | 2.93 B | 2.93 B | 2.58 B | 2.59 B | 2.59 B | 2.59 B | 2.49 B | 2.49 B | 2.49 B | 2.49 B | 2.18 B | 2.19 B | 2.19 B | 2.19 B | 2.19 B | 2.19 B | 2.19 B | 2.19 B | 2.02 B | 2.02 B | 2.01 B | 2.01 B | 1.74 B | 1.74 B | 1.74 B | 1.74 B |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 15.3 B | 1.74 B | 5.27 B |
Total Shareholders Equity of other stocks in the Medical devices industry
| Issuer | Total Shareholders Equity | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Abiomed
ABMD
|
1.33 B | - | - | $ 17.2 B | ||
|
Acutus Medical
AFIB
|
-879 K | - | -26.83 % | $ 2.62 M | ||
|
Apyx Medical Corporation
APYX
|
26.7 M | $ 3.82 | -1.04 % | $ 132 M | ||
|
Apollo Endosurgery
APEN
|
32.6 M | - | - | $ 475 M | ||
|
BioSig Technologies
BSGM
|
-1.54 M | - | 37.08 % | $ 85.7 M | ||
|
Bruker Corporation
BRKR
|
1.78 B | $ 45.69 | 1.24 % | $ 6.81 K | ||
|
Allied Healthcare Products
AHPI
|
5.23 M | - | 3.58 % | $ 2.21 M | ||
|
Abbott Laboratories
ABT
|
47.7 B | $ 128.67 | 2.55 % | $ 224 B | ||
|
Boston Scientific Corporation
BSX
|
21.8 B | $ 91.95 | -0.67 % | $ 135 B | ||
|
Conformis
CFMS
|
54.2 M | - | - | $ 16.4 M | ||
|
EDAP TMS S.A.
EDAP
|
40.9 M | $ 3.18 | 10.56 % | $ 119 M | ||
|
Cardiovascular Systems
CSII
|
249 M | - | 0.15 % | $ 844 M | ||
|
Cutera
CUTR
|
-172 M | - | -10.19 % | $ 1.99 M | ||
|
Neovasc
NVCN
|
1.98 M | - | - | $ 111 M | ||
|
Eargo
EAR
|
101 M | - | - | $ 10.2 M | ||
|
Dynatronics Corporation
DYNT
|
3.26 M | - | 14.99 % | $ 929 K | ||
|
Cognyte Software Ltd.
CGNT
|
198 M | $ 9.58 | -2.84 % | $ 688 M | ||
|
InMode Ltd.
INMD
|
704 M | $ 14.35 | -1.1 % | $ 1.14 B | ||
|
IRIDEX Corporation
IRIX
|
9.52 M | $ 0.99 | 7.52 % | $ 16 M | ||
|
IRadimed Corporation
IRMD
|
86.8 M | $ 96.99 | 0.79 % | $ 1.23 B | ||
|
Second Sight Medical Products
EYES
|
17.6 M | - | -0.97 % | $ 54.4 M | ||
|
Align Technology
ALGN
|
3.85 B | $ 163.04 | -1.44 % | $ 12.2 B | ||
|
Accuray Incorporated
ARAY
|
81.2 M | $ 1.04 | -2.06 % | $ 107 M | ||
|
Avinger
AVGR
|
-6.2 M | - | -20.74 % | $ 369 K | ||
|
ClearPoint Neuro
CLPT
|
25.4 M | $ 12.5 | -1.66 % | $ 338 M | ||
|
FONAR Corporation
FONR
|
150 M | $ 14.9 | 0.99 % | $ 97.7 M | ||
|
AxoGen
AXGN
|
104 M | $ 30.0 | -1.3 % | $ 1.33 B | ||
|
Axonics Modulation Technologies
AXNX
|
570 M | - | - | $ 3.31 B | ||
|
GBS
GBS
|
3 M | - | -0.57 % | $ 7.12 M | ||
|
CONMED Corporation
CNMD
|
963 M | $ 40.3 | -1.29 % | $ 1.24 B | ||
|
LivaNova PLC
LIVN
|
1.32 B | $ 63.28 | 0.84 % | $ 3.43 B | ||
|
OrthoPediatrics Corp.
KIDS
|
355 M | $ 17.83 | 1.31 % | $ 411 M | ||
|
Globus Medical
GMED
|
4.18 B | $ 86.73 | 0.05 % | $ 11.8 B | ||
|
LENSAR
LNSR
|
4.86 M | $ 11.51 | -0.04 % | $ 133 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
1.55 B | $ 13.51 | 0.67 % | $ 1.04 B | ||
|
Aziyo Biologics
AZYO
|
-38.6 M | - | 1.37 % | $ 20.5 M | ||
|
Alphatec Holdings
ATEC
|
-14.2 M | $ 19.79 | -0.85 % | $ 2.83 B | ||
|
Aethlon Medical
AEMD
|
5.12 M | $ 3.07 | -9.71 % | $ 4.79 M | ||
|
Establishment Labs Holdings
ESTA
|
53.1 M | $ 72.39 | -0.17 % | $ 2.04 B |